Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension

Circulation

Volumn 97, Issue 22, 1998, Pages 2222-2229

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Magagna, Armando ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antioxidants; Endothelium; Endothelium derived factors; Free radicals; Hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; PROSTAGLANDIN SYNTHASE; SUPEROXIDE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032499667     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.22.2222     Document Type: Article

References (56)

1. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990:1-215.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
4. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
5. Vallance P, Coller J, Moncada S, Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
6. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rats. Hypertension. 1986;8:344-348.
7. 2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral artery. Blood Vessels. 1987;24:117-119.
8. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990;15:475-482.
9. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol. 1989;257:H33-H37.
10. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
11. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
12. Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
13. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
14. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 1993;87:1475-1481.
15. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol. 1994;23:1610-1616.
16. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile Fasolo C, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation. 1995;91:1981-1987.
17. Panza JA, García CE, Kilcoyne CM, Quyyumi A, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
18. Taddei S, Virdis A, Mattel P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92:2911-2918.
19. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(suppl 1. pt 2):274-279.
20. Kontos HA, Kontos MC. Role of products of univalent reduction of oxygen in hypertensive vascular injury. In: Laragh JH, Brenner, BM, eds. Hypertension: Pathophysiology. Diagnosis, and Management. 2nd ed. New York. NY: Raven Press. Ltd: 1995:685-696.
21. Fridovich I. The biology of oxygen radicals. Science. 1978;201:875-880.
22. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527-605.
23. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived relaxant factor. Nature. 1984;308:645-647.
24. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factors. Am J Physiol. 1986;250:H822-H827.
25. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion plays a role in the breakdown of endothelium-derived relaxing factor. Nature. 1986;320:454-456.
26. Mügge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-dependent relaxing factor depends on endothelial Superoxide dismutase activity. Am J Physiol. 1991;260:C2I9-C225.
27. Sunman W, Hughes AD, Sever PS. Free-radical scavengers, thiol-containing reagents and endothelium-dependent relaxation in isolated rat and human resistance arteries. Clin Sci. 1993;84:287-295.
28. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of Superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26(pt 1):854-857.
29. Tschudi MR, Mesaros S, Lüscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Hypertension. 1996;27:32-35.
30. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension. 1990;15:699-703.
31. Cosentino F, Sill JC, Katusic ZS. Role of Superoxide anions in the mediation of endothelium-3 dependent contraction. Hypertension. 1994;23:229-235.
32. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors, II: endothelium-dependent contraction. Hypertension. 1991;18(suppl III):III-86-III-92.
33. Omar BA, Flores SC, McCord JM. Superoxide dismutase: pharmacological developments and applications. Adv Pharmacol. 1992;23:109-161.
34. Nakazono K, Watanabe N, Matsuno K, Sasak J, Sato T. Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:1045-1048.
35. Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilatation after acute hypertension. Circ Res. 1985;57:781-787.
36. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377-6381.
37. Bendich A, Machlin IJ, Scandurra O, Burton GW, Wayner DDM. The antioxidant role of vitamin C. Adv Free Radic Biol Med. 1986;2:419-444.
38. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1-27.
39. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension. 1986;8:786-792.
40. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750-751.
41. Ting HH, Timini TF, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22-28.
42. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 1996;94:6-9.
43. Garcia CE, Kilcoyne CM, Cardillo C, Cannoo RO III, Quyyumi AA, Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension. 1995;26(pt l):863-868.
44. G-monomethyl-L-arginine in patients with essential hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
45. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidam therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
46. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
47. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ Jr, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991;325:1551-1556.
48. Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerotic influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 1989;83:1946-1952.
49. Virdis A, Taddei S, Ghiadoni L, Sudano I, Di Legge V, Meola M, Salvetti A. Endothelial function and common carotid wall thickening in untreated essential hypertensive patients. J Hypertens. 1996;14(suppl 1):S48. Abstract.
50. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney J, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996;93:1107-1113.
51. Riemersma RA, Wood DA, Macintyre CCH, Elton RA, Gey KF, Oliver MF. Low plasma vitamin E and C and increased risk of angina in Scottish men. Ann N Y Acad Sci. 1989;570:291-295.
52. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet W. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
53. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
54. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Mean Antioxidam Study (CHAOS). Lancet. 1996;347:781-786.
55. The HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evaluation; study: the design of a large, simple randomized trial of an angiotensin convening enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol. 1996;12:127-137.
56. Sleight P. Primary prevention of coronary heart disease in hypertension. J Hypertens. 1996;14(suppl 2):S35-S39.